Have a feature idea you'd love to see implemented?
Let us know!
HCAT Health Catalyst Inc
Price (delayed)
$7.66
Market cap
$466.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.34
Enterprise value
$502.1M
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage
Highlights
HCAT's EPS is up by 40% year-on-year and by 10% since the previous quarter
The net income has grown by 36% YoY and by 8% from the previous quarter
Health Catalyst's quick ratio has plunged by 68% YoY but it has increased by 19% from the previous quarter
The company's debt rose by 47% QoQ and by 46% YoY
The company's equity fell by 3.2% YoY
Key stats
What are the main financial stats of HCAT
Market
Valuations
Earnings
Shares outstanding
60.85M
Market cap
$466.09M
Enterprise value
$502.1M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.3
Price to sales (P/S)
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.66
Revenue
$302.06M
EBIT
-$80.39M
EBITDA
-$36.22M
Free cash flow
-$14.88M
Per share
Balance sheet
Liquidity
EPS
-$1.34
Free cash flow per share
-$0.25
Book value per share
$5.87
Revenue per share
$5
TBVPS
$8.31
Total assets
$813.05M
Total liabilities
$458.01M
Debt
$364.33M
Equity
$355.04M
Working capital
$133.63M
Debt to equity
1.03
Current ratio
1.41
Quick ratio
1.36
Net debt/EBITDA
-0.99
Margins
Efficiency
Dividend
EBITDA margin
-12%
Gross margin
45.2%
Net margin
-26.2%
Operating margin
-28.2%
Return on assets
-10.9%
Return on equity
-22%
Return on invested capital
-25.8%
Return on capital employed
-16.4%
Return on sales
-26.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCAT stock price
How has the Health Catalyst stock price performed over time
Intraday
4.08%
1 week
-9.35%
1 month
-10.93%
1 year
1.59%
YTD
-17.28%
QTD
-5.9%
Financial performance
How have Health Catalyst's revenue and profit performed over time
Revenue
$302.06M
Gross profit
$136.6M
Operating income
-$85.09M
Net income
-$79.14M
Gross margin
45.2%
Net margin
-26.2%
The company's net margin rose by 38% YoY and by 9% QoQ
The operating margin rose by 37% YoY and by 12% QoQ
The net income has grown by 36% YoY and by 8% from the previous quarter
The operating income is up by 35% year-on-year and by 11% since the previous quarter
Growth
What is Health Catalyst's growth rate over time
Valuation
What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.3
P/S
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.66
HCAT's EPS is up by 40% year-on-year and by 10% since the previous quarter
HCAT's price to book (P/B) is 58% lower than its 5-year quarterly average of 3.1
The company's equity fell by 3.2% YoY
The stock's price to sales (P/S) is 69% less than its 5-year quarterly average of 5.0 but 2% more than its last 4 quarters average of 1.5
The company's revenue rose by 4.2% YoY
Efficiency
How efficient is Health Catalyst business performance
HCAT's ROS is up by 39% year-on-year and by 13% since the previous quarter
Health Catalyst's return on assets has increased by 37% YoY and by 12% QoQ
HCAT's return on equity is up by 32% year-on-year and by 8% since the previous quarter
The ROIC has contracted by 8% from the previous quarter
Dividends
What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCAT.
Financial health
How did Health Catalyst financials performed over time
HCAT's total assets is 78% greater than its total liabilities
Health Catalyst's quick ratio has plunged by 68% YoY but it has increased by 19% from the previous quarter
The current ratio has plunged by 68% YoY but it has grown by 19% from the previous quarter
The company's debt is 2.6% higher than its equity
The debt to equity has soared by 51% year-on-year and by 47% since the previous quarter
The company's debt rose by 47% QoQ and by 46% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.